ACCRUED EXPENSES

12 Months Ended

Dec. 31, 2022

Payables and Accruals [Abstract]

ACCRUED EXPENSES

10.ACCRUED EXPENSES

Accrued expenses consisted of the following:

	December 31, 2022		December 31, 2021
Accrued pre-clinical and clinical costs	$	2,137,317	$	5,435,464
Accrued product development costs		247,500		203,676
Accrued compensation		2,224,951		2,715,368
Accrued administrative costs		473,376		1,213,699
Accrued interest		916,108		525,105
Total	$	5,999,252	$	10,093,312